SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-062803
Filing Date
2018-10-18
Accepted
2018-10-18 17:00:59
Documents
9
Effectiveness Date
2018-10-18

Document Format Files

Seq Description Document Type Size
1 DFAN14A a18-36875_2dfan14a.htm DFAN14A 46602
2 GRAPHIC g368752bci001.jpg GRAPHIC 126492
3 GRAPHIC g368752bci002.jpg GRAPHIC 278602
4 GRAPHIC g368752bci003.jpg GRAPHIC 129239
5 GRAPHIC g368752bci004.jpg GRAPHIC 96414
6 GRAPHIC g368752bci005.jpg GRAPHIC 103318
7 GRAPHIC g368752bci006.jpg GRAPHIC 105691
8 GRAPHIC g368752bci007.jpg GRAPHIC 73070
9 GRAPHIC g368752bci008.jpg GRAPHIC 87347
  Complete submission text file 0001104659-18-062803.txt   1426528
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Subject) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-35050 | Film No.: 181128806
SIC: 2834 Pharmaceutical Preparations